ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

NEXT STORY
Coastline’s Acquired Brain Injury (ABI) Program is partnering with Brain Strategies & Technology (BEST) and Global Brain Injury Awareness (GBIA) to Celebrate Brain Injury Awareness Month
PREV STORY
Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Neothetics Reports Third Quarter 2015 Financial Results

SAN DIEGO, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty ...

author_avatar
NASDAQ Market News

Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Dear Sorrento Stockholders, Since its inception ...

author_avatar
NASDAQ Market News

NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (6.30 pm CEST) - Ablynx NV [Euronext ...

author_avatar
NASDAQ Market News